Msh2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect
- 5 December 2005
- journal article
- Published by Springer Nature in Oncogene
- Vol. 25 (17) , 2531-2536
- https://doi.org/10.1038/sj.onc.1209277
Abstract
Msh2 is a key mammalian DNA mismatch repair (MMR) gene and mutations or deficiencies in mammalian Msh2 gene result in microsatellite instability (MSI+) and the development of cancer. Here, we report that primary mouse embryonic fibroblasts (MEFs) deficient in the murine MMR gene Msh2 (Msh2-/-) showed a significant increase in chromosome aneuploidy, centrosome amplification, and defective mitotic spindle organization and unequal chromosome segregation. Although Msh2-/- mouse tissues or primary MEFs had no apparent change in telomerase activity, telomere length, or recombination at telomeres, Msh2-/- MEFs showed an increase in chromosome end-to-end fusions or chromosome ends without detectable telomeric DNA. These data suggest that MSH2 helps to maintain genomic stability through the regulation of the centrosome and normal telomere capping in vivo and that defects in MMR can contribute to oncogenesis through multiple pathways.Keywords
This publication has 20 references indexed in Scilit:
- Centrosome control of the cell cycleTrends in Cell Biology, 2005
- Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cellsNucleic Acids Research, 2004
- Telomeric Recombination in Mismatch Repair Deficient Human Colon Cancer Cells after Telomerase InhibitionCancer Research, 2004
- Centrosome aberrations: cause or consequence of cancer progression?Nature Reviews Cancer, 2002
- Protection of mammalian telomeresOncogene, 2002
- Functional interactions and signaling properties of mammalian DNA mismatch repair proteinsCell Death & Differentiation, 2001
- Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrationsGenes, Chromosomes and Cancer, 2000
- Mammalian DNA Mismatch RepairAnnual Review of Genetics, 1999
- Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP)Nucleic Acids Research, 1997
- Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancerCell, 1995